Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.36% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 0.89% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBAI
11251
Check-Cap
MBAI
$9.89M
| $49.7K | ﹤0.01% |
+1,618
| New | +$36.6K |
|
|
ATHX
11252
DELISTED
Athersys, Inc. Common Stock
ATHX
| $49.6K | ﹤0.01% |
114,835
+86,028
| +299% | +$47K |
|
|
NXDR
11253
Nextdoor Holdings
NXDR
$897M
| $49.5K | ﹤0.01% |
27,216
-57,797
| -68% | -$143K |
|
11254
Dyadic International
DYAI
$27.6M
| $49.5K | ﹤0.01% |
+25,786
| New | +$48.1K |
|
11255
BioXcel Therapeutics
BTAI
$23.4M
| $49.2K | ﹤0.01% |
1,216
-14,471
| -92% | -$1.46M |
|
11256
PUT
InflaRx
IFRX
$360M
| $49.2K | ﹤0.01% |
16,500
+6,100
| +59% | +$23.2K |
|
|
AKTS
11257
CALL
DELISTED
Akoustis Technologies Inc
AKTS
| $49K | ﹤0.01% |
65,400
+9,100
| +16% | +$16.8K |
|
11258
Avalon Holdings
AWX
$10.5M
| $49K | ﹤0.01% |
25,281
-12,074
| -32% | -$27.8K |
|
|
STKL
11259
PUT
DELISTED
SunOpta
STKL
| $48.9K | ﹤0.01% |
14,500
-800
| -5% | -$4.01K |
|
11260
Verrica Pharmaceuticals
VRCA
$83.1M
| $48.8K | ﹤0.01% |
1,256
-3,877
| -76% | -$197K |
|
|
SIEN
11261
CALL
DELISTED
Sientra, Inc.
SIEN
| $48.6K | ﹤0.01% |
17,500
-18,200
| -51% | -$56K |
|
11262
PUT
Harvard Bioscience
HBIO
$34.6M
| $48.6K | ﹤0.01% |
+1,130
| New | +$52.1K |
|
|
RGLS
11263
CALL
DELISTED
Regulus Therapeutics
RGLS
| $48.6K | ﹤0.01% |
35,200
-8,800
| -20% | -$12.8K |
|
11264
Achieve Life Sciences
ACHV
$841M
| $48.5K | ﹤0.01% |
+11,290
| New | +$56.9K |
|
11265
Rocky Mountain Chocolate Factory
RMCF
$10.5M
| $48.2K | ﹤0.01% |
+10,037
| New | +$53.3K |
|
11266
CALL
OppFi
OPFI
$617M
| $48.1K | ﹤0.01% |
19,100
-9,000
| -32% | -$20.9K |
|
11267
CALL
Outdoor Holding Co
POWW
$256M
| $47.9K | ﹤0.01% |
23,700
-144,900
| -86% | -$304K |
|
11268
Angi Inc
ANGI
$196M
| $47.8K | ﹤0.01% |
2,412
-3,137
| -57% | -$89.8K |
|
11269
Arq
ARQ
$92.6M
| $47.2K | ﹤0.01% |
+26,493
| New | +$51.7K |
|
11270
Arqit Quantum
ARQQ
$351M
| $47K | ﹤0.01% |
3,158
-4,092
| -56% | -$99.9K |
|
11271
CALL
Pyxis Oncology
PYXS
$259M
| $47K | ﹤0.01% |
23,600
-3,800
| -14% | -$8.8K |
|
11272
Ceragon Networks
CRNT
$188M
| $46.9K | ﹤0.01% |
+22,862
| New | +$46.2K |
|
|
ADN
11273
CALL
DELISTED
Advent Technologies
ADN
| $46.8K | ﹤0.01% |
4,003
+513
| +15% | +$10.1K |
|
|
GRND.WS
11274
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
| $46.5K | ﹤0.01% |
+58,854
| New | +$44.3K |
|
|
SANW
11275
DELISTED
S&W Seed Co
SANW
| $46.4K | ﹤0.01% |
2,182
+42
| +2% | +$843 |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.